Inactive Instrument

News Biotech Acquisition Company Nasdaq

Equities

BIOTU

KYG1125A1242

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

BIOTECH ACQUISITION CO : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	02/23/02	AQ
Biotech Acquisition to Dissolve, Liquidate	02/23/02	MT
Biotech Acquisition Company(NasdaqCM:BIOT) dropped from NASDAQ Composite Index	02/23/02	CI
Biotech Acquisition Company Announces Liquidation	02/23/02	GL
Biotech Acquisition Company Announces Liquidation	02/23/02	AQ
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	26/23/26	AQ
BIOTECH ACQUISITION CO : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	11/23/11	AQ
Biotech Acquisition Says New Sponsor to Make Additional Contributions Related to Proposed Business Combination Extension	05/23/05	MT
Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment	05/23/05	PR
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement (form 8-K)	23/22/23	AQ
Biotech Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/22/22	AQ
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	12/22/12	AQ
Biotech Acquisition Company announced that it expects to receive $0.25 million in funding	04/22/04	CI
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/22/23	AQ
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference	01/22/01	BU
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	18/22/18	AQ
Biotech Acquisition : and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement - Form 8-K	13/22/13	PU
Biotech Acquisition, Blade Therapeutics Agree to Terminate Merger Agreement	13/22/13	MT
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	13/22/13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biotech Acquisition Company Nasdaq

Equities

BIOTU

KYG1125A1242

Summary

Filters